EMBLA Embla Medical hf.

4.028USD27.45 DKK · CPH+0.37%Mkt Cap: 1.71B USDP/E: 19.33

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neu…

Institutional holders3 on file

Key Statistics

Company
Market Cap1.71B USD
Enterprise Value1.77B USD
Revenue (TTM)997.24M USD
Gross Profit578.55M USD
Net Income (TTM)83.34M USD
Revenue/Share2.34 USD
Last Price4.028 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees4.5K
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINIS0000000040
Valuation
P/E (Trailing)19.33
P/E (Forward)15.81
PEG—
EV/EBITDA76.34
EV/Revenue1.78
P/S11.70
P/B1.86
EPS (TTM)1.42 USD
EPS (Forward)1.74 USD
52W Range
3.66919% of range5.561
52W High5.561 USD
52W Low3.669 USD
Profitability
Gross Margin62.30%
Oper. Margin13.56%
EBITDA Margin15.88%
Profit Margin8.97%
ROE9.36%
ROA4.82%
ROIC7.24%
ROCE8.78%
Growth
Revenue Growth5.40%
Earnings Growth1.70%
Cash Flow & Leverage
Operating CF132.62M USD
CapEx (TTM)32.33M USD
FCF Margin8.82%
FCF Yield5.14%
Net Debt414.44M USD
Net Debt/EBITDA2.62
Net Debt/FCF4.71
Balance Sheet
Debt/Equity0.61
Current Ratio1.28
Quick Ratio0.64
Book Value/Sh14.79 USD
Cash/Share0.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield0.36%
Payout Ratio0.00%
Ex-Div DateMar 13, 2020
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.681 USD
Upside (mean)+16.2%
Target Range4.182 USD – 5.136 USD
4.182+16.2% to mean5.136
# Analysts5
Ownership
Shares Out.424.97M
Float155.91M
Insiders11.69%
Institutions78.72%
Technical
SMA 504.007 (+0.5%)
SMA 2004.074 (-1.1%)
Beta0.46
S&P 52W Chg12.00%
Avg Vol (30d)154.91K
Avg Vol (10d)345.79K
Technical Indicators
RSI (14)48.9
MACD0.1021
MACD Signal0.1327
MACD Hist.-0.0306
BB Upper4.203 USD
BB Middle4.038 USD
BB Lower3.873 USD
BB Width8.17%
ATR (14)0.1029 USD
Vol Ratio (20d)0.42x

About Embla Medical (CPH: EMBLA)

›

Embla Medical (CPH: EMBLA) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 4,500 employees.

The shares were at 27.45 DKK on 19 November 2026, down 19.5% over 52 weeks. Its 52-week range is 25.00 DKK to 37.90 DKK: the price is 27.6% below the high and 9.8% above the low.

At a market capitalisation of 11.67B DKK, it trades at 19.3 times trailing earnings and 15.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 25% for EMBLA.

Embla Medical reports return on equity of 9.4%, an operating margin of 13.6% and revenue up 5.4% year over year.

Its debt exceeds its cash by 414.44M USD, a debt-to-equity ratio of 0.61. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 31.90 DKK is 16.2% above the current price. The next earnings report is expected on 2 February 2027.